The Effects on Obesity Related Peptides of Laparoscopic Gastric Band Applications in Morbidly Obese Patients

References

• World Health Organization. Obesity preventing and managing the global epidemic. Geneva, Switzerland: World Health Organization; 1998.
   Google Scholar
• Donahue RP, Abbot RD, Bloom E, et al. Central obesity and coronary heart disease. Lancet. 1987;1:821–824.
   PubMed Web of Science ®Google Scholar
• Bloomgarden Z. Obesity and diabetes. iabetes Care. 2000;23:1584–1590.
   PubMed Web of Science ®Google Scholar
• Sjöström L. Mortality of severely obese subjects. Am J ClinNutr. 1992;55:516–523S.
   PubMed Web of Science ®Google Scholar
• Richman RM, Elliott LM, Burns CM, et al. The prevalence of obstructive sleep apnea in an obese female population. Int J Obes Relat Metab Disord. 1994;18:173–177.
   PubMed Web of Science ®Google Scholar
• Kampe J, Stefanidis A, Lockie SH, et al. Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model. Int J Obes (Lond). 2012;36:1403–1411.
   PubMed Web of Science ®Google Scholar
• Muniyappa R, Lee S, Chen H, et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15–E26.
   PubMed Web of Science ®Google Scholar
• Steinberger J, Daniels SR, American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young), American Heart Association Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation. 2003;107:1448–1453.
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–312.
   PubMed Web of Science ®Google Scholar
• Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol. 2008;90:343–349.
   PubMed Web of Science ®Google Scholar
• Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282:28175–28188.
   PubMed Web of Science ®Google Scholar
• Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148:4687–4694.
   PubMed Web of Science ®Google Scholar
• Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426–430.
   PubMed Web of Science ®Google Scholar
• Hubbard VS, Hall WH. Gastrointestinal surgery for severe obesity. National Institutes of Health consensus development conference draft statement. Obes Surg. 1991;1:257–265.
   PubMedGoogle Scholar
• Deitel M, Greenstein RJ. Recommendations for reporting weight loss. Obes Surg. 2003;13:159–160.
   PubMed Web of Science ®Google Scholar
• Alley JB, Fenton SJ, Harnisch MC, et al. Quality of life after sleeve gastrectomy and adjustable gastric banding. Surg Obes Relat Dis. 2012;8:31–40.
   PubMed Web of Science ®Google Scholar
• Goktas Z, Moustaid-Moussa N, Shen CL, et al. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne). 2013;4:69.
   PubMedGoogle Scholar
• Edwards C, Hindle AK, Fu S, Brody F. Downregulation of leptin and resistin expression in blood following bariatric surgery. Surg Endosc. 2011;25:1962–1968.
   PubMed Web of Science ®Google Scholar
• Marantos G, Daskalakis M, Karkavitsas N, et al. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg. 2011;35:2022–2030.
   PubMed Web of Science ®Google Scholar
• Tomasz S, Dominika S, Iwona KS, et al. Long-term effect of ileal transposition on adipokine serum level in Zucker (Orl)-Lepr(fa) fatty rats. Obes Surg. 2015;25:1848–1857.
   PubMed Web of Science ®Google Scholar
• Moschen AR, Molnar C, Weiss H, et al. Effects of weight loss induced by bariatric surgery on hepatic adipocytokines expression. J Hepatol. 2009;51:765–777.
   PubMed Web of Science ®Google Scholar
• de Luis DA, Terroba MC, Cuellar L, et al. Resistin levels in morbid obese patients following the biliopancreatic diversion surgery. Horm Metab Res. 2011;43:205–208.
   PubMed Web of Science ®Google Scholar
• Jankiewicz-Wika J, Kołomecki K, Cywiński J, et al. Impact of vertical banded gastroplasty on body weight, insulin resistance, adipocytokine, inflammation and metabolic syndrome markers in morbidly obese patients. Endokrynol Pol. 2011;62:109–119.
   PubMed Web of Science ®Google Scholar
• Lee SE, Kim HS. Human resistin in cardiovascular disease. J Smooth Muscle Res. 2012;48:27–35.
   PubMedGoogle Scholar
• Castan-Laurell I, Boucher J, Dray C, et al. Apelin, a novel adipokine over-produced in obesity: friend or foe? Mol Cell Endocrinol.2005;245:7–9.
   PubMed Web of Science ®Google Scholar
• Krist J, Wieder K, Klöting N, et al. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts.2013;6:57–69.
   PubMed Web of Science ®Google Scholar
• Caron-Cantin SM, Martin J, Bastien M, et al. Acute and chronic effects of biliopancreatic diversion with duodenal switch surgery on plasma visfatin and apelin levels in patients with severe obesity. Obes Surg. 2013;23:1806–1814.
   PubMed Web of Science ®Google Scholar
• Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg. 2009;19:1574–1580.
   PubMed Web of Science ®Google Scholar
• Heinonen MV, Purhonen AK, Miettinen P, et al. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept. 2005;130:7–13.
   PubMed Web of Science ®Google Scholar
• Terra X, Auguet T, Guiu-Jurado E, et al. Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2013;23:1790–1798.
   PubMed Web of Science ®Google Scholar
• Sell H, Divoux A, Poitou C, et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2010;95:2892–2896.
   PubMed Web of Science ®Google Scholar
• Auguet T, Terra X, Hernández M, et al. Clinical and adipocytokine changes after bariatric surgery in morbidly obese women. Obesity (Silver Spring). 2014;22:188–194.
   PubMed Web of Science ®Google Scholar
• Manco M, Fernandez-Real JM, Equitani F, et al. Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab. 2007;92:483–490.
   PubMed Web of Science ®Google Scholar
• Haider DJ, Schindler K, Schaller G, et al. Increased visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin EndocrinolMetab 2006;91:1578–1581.
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh-Attar MJ, Golpaie A, Janani L, et al. Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects. Obes Facts. 2013;6:193–202.
   PubMed Web of Science ®Google Scholar
• Terra X, Auguet T, Quesada I, et al. Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines. Clin Endocrinol (Oxf). 2012;77:691–698.
   PubMed Web of Science ®Google Scholar
• Kukla M, Ciupińska-Kajor M, Kajor M, et al. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. Pol J Pathol. 2010;61:147–153.
   PubMed Web of Science ®Google Scholar
• Karbaschian Z, Hosseinzadeh-Attar MJ, Giahi L, et al. Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery. Endocrine. 2013;44:114–118.
   PubMed Web of Science ®Google Scholar
• Auguet T, Terra X, Porras JA, et al. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease. Clin Biochem. 2013;46:202–208.
   PubMed Web of Science ®Google Scholar
• de Luis DA, Izaola O, Conde R, et al. Visfatin levels in female, morbid, nondiabetic obese patients after biliopancreatic diversion surgery. Surg Obes Relat Dis. 2011;7:195–198.
   PubMed Web of Science ®Google Scholar
• Botella-Carretero JI, Luque-Ramírez M, Alvarez-Blasco F, et al. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes Surg. 2008;18:1000–1006.
   PubMed Web of Science ®Google Scholar
• García-Fuentes E, García-Almeida JM, García-Arnés J, et al. Plasma visfatin concentrations in severely obese subjects are increased after intestinal bypass. Obesity (Silver Spring). 2007;15:2391–2395.
   PubMed Web of Science ®Google Scholar